Targeting CA 19-9 with a humanized monoclonal antibody at the time of surgery ma
- This topic has 0 replies, 1 voice, and was last updated 4 years, 2 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Targeting CA 19-9 with a humanized monoclonal antibody at the time of surgery may decrease recurrence rates for patients undergoing resections for pancreatic cancer, cholangiocarcinoma and metastatic colorectal cancer.
https://www.ncbi.nlm.nih.gov/pubmed/32399263
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.